Search

everythinglearnresearchcommunity

for

Search:↓

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

CEOs aged 50-69 have less significant hair loss than the general white male population.

CEOs aged 50-69 have less significant hair loss than the general white male population.

More severe hair loss worsens quality of life in men.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Cyclosporin doesn't stop hair loss.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Using a laser with minoxidil was more effective for hair loss than minoxidil alone.

There is no link between hair loss and prostate enlargement.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Younger men with hair loss have a worse quality of life.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

In Bishan, Singapore, 63% of men have androgenetic alopecia, a type of hair loss, with rates increasing with age and more common in Indians than Chinese.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Andropause is strongly associated with hair loss in male civil servants.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Topical cetirizine helps treat male hair loss.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Men with early-onset hair loss have more heart disease risk factors.

Androgenetic alopecia is significantly linked to metabolic syndrome.